553P Activity of trastuzumab and pertuzumab (HP) in patients with non-breast/gastroesophgeal HER2-amplified tumours: Results of the NCI-MATCH trial (EAY131) subprotocol J R.M. Connolly,V. Wang,D.M. Hyman,P. Grivas,E. Mitchell,J. Wright,E. Sharon,R.J. Gray,S. Li,L. McShane,L. Rubinstein, D.R. Patton,P.M. Williams, S. Hamilton,B. Conley,C.L. Arteaga,L. Harris, P.J. O'Dwyer,A. Chen,K.T. FlahertyAnnals of Oncology（2020）引用 2|浏览63暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
